MLM Medical Labs Acquires CirQuest Labs
July 9, 2020
MLM Medical Labs, a Great Point Partners portfolio company, acquired Memphis-based CirQuest Labs to establish a U.S. presence and create a globally integrated central lab platform. CirQuest — a specialist in assay development, biomarker testing, and central lab services for drug development — will join MLM’s global operations and its founder, Dr. Lisa K. Jennings, will take on a scientific leadership role.
- Buyers
- MLM Medical Labs, Great Point Partners
- Targets
- CirQuest Labs
- Sellers
- Lisa K. Jennings (founder & owner)
- Platforms
- MLM Medical Labs
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
MLM Medical Labs Acquires MD Biosciences, Inc.
October 27, 2020
Healthcare Services
MLM Medical Labs, a Great Point Partners portfolio company, has acquired MD Biosciences, Inc., an Oakdale, Minnesota-based provider of preclinical, translational and clinical-phase contract research services. The deal expands MLM's U.S. footprint and adds immunohistochemistry, preclinical research and histopathology capabilities to its global laboratory platform as part of an integration with recent U.S. additions such as CirQuest Labs.
-
Centers Laboratory LLC Acquires Medical Laboratory Diagnostics (MedLabs) from Caymus Equity Partners
September 1, 2019
Healthcare Services
Centers Laboratory LLC acquired Medical Laboratory Diagnostics, LLC (MedLabs) from Caymus Equity Partners; the transaction closed on September 16, 2019. MedLabs, headquartered in Cedar Knolls, New Jersey, operates 26 patient service centers and provides clinical diagnostic testing to thousands of physician customers.
-
Medical Laboratory Diagnostics (MedLabs) Acquires Mercy Diagnostics
April 1, 2019
Healthcare Services
Caymus Equity Partners’ portfolio company Medical Laboratory Diagnostics, LLC (MedLabs) acquired Mercy Diagnostics, Inc., a Mount Laurel, New Jersey clinical diagnostics laboratory. The add-on transaction closed on April 24, 2019 and is MedLabs’ first strategic acquisition since the company’s majority recapitalization in March 2018.
-
Quest Diagnostics Acquires Labtech Diagnostics
December 14, 2021
Healthcare Services
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
-
Discovery Life Sciences Acquires QualTek Molecular Laboratories
May 5, 2019
Healthcare Services
Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.
-
Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B
July 8, 2024
Healthcare Services
Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.